David C Dale1, Audrey Anna Bolyard2, Laurie A Steele1, Cornelia Zeidler3, Karl Welte4. 1. Department of Medicine, University of Washington, Seattle, Washington. 2. University of Washington, Severe Chronic Neutropenia International Registry, Seattle, Washington, USA. 3. Department of Hematology, Hemostasis, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. 4. Department of Hematology/Oncology, University Hospital Tübingen, Tübingen, Germany.
Abstract
PURPOSE OF REVIEW: Registries provide 'real world' perspectives on the natural history and outcomes for many clinical conditions. The purpose of this review is to identify registries for nonmalignant hematological disease and to describe the operation of a successful long-term registry for patients with severe chronic neutropenia. RECENT FINDINGS: There was an upswing in registries about 20 years ago, based on optimism about their utility to improve patient care. To show value, registries must define outcomes for populations of patients with specific medical conditions and the effects of treatment. This is challenging for many reasons. The Severe Chronic Neutropenia International Registry is an example of a successful registry. This report describes underlying reasons for its success. SUMMARY: Registries are important to organize and analyze clinical information across geographic, ethnic and social boundaries. They are also challenging to organize, administer and support.
PURPOSE OF REVIEW: Registries provide 'real world' perspectives on the natural history and outcomes for many clinical conditions. The purpose of this review is to identify registries for nonmalignant hematological disease and to describe the operation of a successful long-term registry for patients with severe chronic neutropenia. RECENT FINDINGS: There was an upswing in registries about 20 years ago, based on optimism about their utility to improve patient care. To show value, registries must define outcomes for populations of patients with specific medical conditions and the effects of treatment. This is challenging for many reasons. The Severe Chronic Neutropenia International Registry is an example of a successful registry. This report describes underlying reasons for its success. SUMMARY: Registries are important to organize and analyze clinical information across geographic, ethnic and social boundaries. They are also challenging to organize, administer and support.
Authors: Vahagn Makaryan; Merideth L Kelley; Breanna Fletcher; Audrey Anna Bolyard; A Andrew Aprikyan; David C Dale Journal: J Leukoc Biol Date: 2017-07-28 Impact factor: 4.962
Authors: Kaan Boztug; Philip S Rosenberg; Marie Dorda; Siddharth Banka; Thomas Moulton; Julie Curtin; Nima Rezaei; John Corns; Jeffrey W Innis; Zekai Avci; Hung Chi Tran; Isabelle Pellier; Paolo Pierani; Rachel Fruge; Nima Parvaneh; Setareh Mamishi; Rajen Mody; Phil Darbyshire; Jayashree Motwani; Jennie Murray; George R Buchanan; William G Newman; Blanche P Alter; Laurence A Boxer; Jean Donadieu; Karl Welte; Christoph Klein Journal: J Pediatr Date: 2011-11-01 Impact factor: 4.406
Authors: Vahagn Makaryan; Willem Kulik; Frederic M Vaz; Christopher Allen; Yigal Dror; David C Dale; Andrew A Aprikyan Journal: Eur J Haematol Date: 2011-12-04 Impact factor: 2.997
Authors: K Welte; E Platzer; L Lu; J L Gabrilove; E Levi; R Mertelsmann; M A Moore Journal: Proc Natl Acad Sci U S A Date: 1985-03 Impact factor: 11.205
Authors: J D M Edgar; M Buckland; D Guzman; N P Conlon; V Knerr; C Bangs; V Reiser; Z Panahloo; S Workman; M Slatter; A R Gennery; E G Davies; Z Allwood; P D Arkwright; M Helbert; H J Longhurst; S Grigoriadou; L A Devlin; A Huissoon; M T Krishna; S Hackett; D S Kumararatne; A M Condliffe; H Baxendale; K Henderson; C Bethune; C Symons; P Wood; K Ford; S Patel; R Jain; S Jolles; T El-Shanawany; H Alachkar; A Herwadkar; R Sargur; A Shrimpton; G Hayman; M Abuzakouk; G Spickett; C J Darroch; S Paulus; S E Marshall; E M McDermott; P T Heath; R Herriot; S Noorani; M Turner; S Khan; B Grimbacher Journal: Clin Exp Immunol Date: 2014-01 Impact factor: 4.330
Authors: Karin Travers; Rachel H Sallum; Meghan D Burns; Charles E Barr; Mary S Beattie; Chris L Pashos; Bryan R Luce Journal: Pharmacoepidemiol Drug Saf Date: 2014-07-31 Impact factor: 2.890
Authors: Taxiarchis Konstantinos Nikolouzakis; Konstantinos Spyridakis; Maria Tzardi; Grigorios Tsaknakis; Maria Ximeri; Maksim Klimiankou; Emmanuel Chrysos; Julia Skokowa; Helen A Papadaki Journal: Ann Hematol Date: 2022-01-27 Impact factor: 3.673
Authors: Erasmia Boutakoglou; Maksim Klimiankou; Grigorios Tsaknakis; Elias Drakos; Julia Skokowa; Helen A Papadaki Journal: Ann Hematol Date: 2022-09-16 Impact factor: 4.030
Authors: David C Dale; Audrey Anna Bolyard; James A Shannon; James A Connelly; Daniel C Link; Mary Ann Bonilla; Peter E Newburger Journal: Blood Adv Date: 2022-07-12
Authors: Helen A Papadaki; Irene Mavroudi; Antonio Almeida; Juergen Bux; Joanna Cichy; David C Dale; Jean Donadieu; Petter Höglund; Oliver Karanfilski; Cristina Mecucci; Jan Palmblad; Julia Skokowa; Kostas Stamatopoulos; Ivo Touw; Alan J Warren; Karl Welte; Cornelia Zeidler; Carlo Dufour Journal: Hemasphere Date: 2020-06-08